• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿坎酸通过 FXR/LXRs 依赖性途径调节非酒精性脂肪性肝病中的脂肪生成。

Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR/LXRs-dependent manner.

机构信息

Key Laboratory for Natural Resource of ChangBai Mountain & Functional Molecules, Ministry of Education, College of Pharmacy, Yanbian University, Yanji, Jilin Province, 133002, China.

Key Laboratory for Natural Resource of ChangBai Mountain & Functional Molecules, Ministry of Education, College of Pharmacy, Yanbian University, Yanji, Jilin Province, 133002, China; Clinical Research Center, Affiliated Hospital of Yanbian University, Yanji, Jilin Province, 133002, China.

出版信息

Chem Biol Interact. 2019 Sep 25;311:108794. doi: 10.1016/j.cbi.2019.108794. Epub 2019 Aug 14.

DOI:10.1016/j.cbi.2019.108794
PMID:31421115
Abstract

Acanthoic acid (AA) is a pimaradiene diterpene isolated from Acanthopanax koreanum Nakai (Araliaceae), with anti-inflammatory and hepatic-protective effects. The present study intended to reveal the effect and mechanism of AA on nonalcoholic fatty liver disease (NAFLD) associated with lipid accumulation by activating Farnesoid X receptor (FXR) and liver X receptors (LXRs) signaling. C57BL/6 mice were received a modified Lieber-DeCarli diet with 71% high-fat (L-D) and treated with AA (20 and 40 mg/kg) or equal volume of saline for 12 weeks. The regulation of AA on lipid accumulation was also detected in pro-steatotic stimulated AML12 cells with palmitic acid (PA). When L-D diet-fed mice were treated with AA, loss in body weight, liver index, and liver lipid droplet were observed along with reduced triglyceride (TG) and serum transaminase. Furthermore, AA decreased sterol regulatory element binding protein 1 (SREBP-1) and target genes expression, regulated PPARα and PPARγ expressions, ameliorated hepatic fibrosis markers, enhanced hepatic FXR and LXR, and regulated AMPK-LKB1 and SIRT1 signaling pathway. Moreover, AA attenuated lipid accumulation via FXR and LXR activation in steatotic AML-12 cells, which was confirmed by guggulsterones (FXR antagonist) or GW3965 (LXR agonist). Activation of FXR and LXR signaling caused by AA might increase AMPK-SIRT1 signaling and then contribute to modulating lipid accumulation and fatty acid synthesis, which suggested that activated FXR-LXR axis by AA represented an effective strategy for relieving NAFLD.

摘要

刺囊酸(AA)是从刺五加(五加科)中分离得到的一种松香二萜,具有抗炎和保肝作用。本研究旨在通过激活法尼醇 X 受体(FXR)和肝 X 受体(LXRs)信号通路,揭示 AA 对脂肪堆积相关的非酒精性脂肪性肝病(NAFLD)的作用及机制。C57BL/6 小鼠给予 71%高脂肪(L-D)改良 Lieber-DeCarli 饮食,并给予 AA(20 和 40mg/kg)或等体积生理盐水治疗 12 周。还在棕榈酸(PA)刺激的前脂肪细胞 AML12 中检测 AA 对脂肪堆积的调节作用。当 L-D 饮食喂养的小鼠用 AA 治疗时,观察到体重、肝指数和肝脂肪滴丢失,同时甘油三酯(TG)和血清转氨酶降低。此外,AA 降低固醇调节元件结合蛋白 1(SREBP-1)和靶基因表达,调节过氧化物酶体增殖物激活受体α和γ(PPARα 和 PPARγ)表达,改善肝纤维化标志物,增强肝 FXR 和 LXR,并调节 AMPK-LKB1 和 SIRT1 信号通路。此外,AA 通过激活 FXR 和 LXR 减少脂肪细胞内的脂肪堆积,在脂肪变性的 AML-12 细胞中证实了这一点,这可以通过 guggulsterones(FXR 拮抗剂)或 GW3965(LXR 激动剂)证实。AA 激活 FXR 和 LXR 信号可能会增加 AMPK-SIRT1 信号,从而有助于调节脂质积累和脂肪酸合成,这表明 AA 激活的 FXR-LXR 轴代表了缓解 NAFLD 的有效策略。

相似文献

1
Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR/LXRs-dependent manner.阿坎酸通过 FXR/LXRs 依赖性途径调节非酒精性脂肪性肝病中的脂肪生成。
Chem Biol Interact. 2019 Sep 25;311:108794. doi: 10.1016/j.cbi.2019.108794. Epub 2019 Aug 14.
2
Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice.藏红花酸通过激活 db/db 小鼠的 AMPK 信号通路改善肝脂肪变性。
Lipids Health Dis. 2019 Jan 8;18(1):11. doi: 10.1186/s12944-018-0955-6.
3
Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.法尼酯X受体(FXR)对肝脏脂质蓄积的保护作用由肝脏FXR介导,且独立于肠道FGF15信号。
Liver Int. 2015 Apr;35(4):1133-1144. doi: 10.1111/liv.12456. Epub 2014 Feb 7.
4
Acanthoic acid, a diterpene in Acanthopanax koreanum, ameliorates the development of liver fibrosis via LXRs signals.刺五加酸,一种朝鲜刺五加中的二萜类化合物,通过肝X受体信号改善肝纤维化的发展。
Chem Biol Interact. 2014 Jul 25;218:63-70. doi: 10.1016/j.cbi.2014.04.016. Epub 2014 May 5.
5
Schaftoside alleviates HFD-induced hepatic lipid accumulation in mice via upregulating farnesoid X receptor.芝麻素通过上调法尼醇 X 受体缓解 HFD 诱导的小鼠肝脂质积累。
J Ethnopharmacol. 2020 Jun 12;255:112776. doi: 10.1016/j.jep.2020.112776. Epub 2020 Mar 20.
6
Acanthoic acid protectsagainst ethanol-induced liver injury: Possible role of AMPK activation and IRAK4 inhibition.刺鼠酸可预防乙醇诱导的肝损伤:AMPK激活和IRAK4抑制的潜在作用。
Toxicol Lett. 2017 Nov 5;281:127-138. doi: 10.1016/j.toxlet.2017.09.020. Epub 2017 Sep 28.
7
Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.虾青素和安卡黄素作为天然 AMPK 激活剂,具有 PPARα 激动剂活性,可下调高脂饮食喂养的 C57BL/6 小鼠的非酒精性脂肪性肝炎。
Food Chem Toxicol. 2014 Feb;64:94-103. doi: 10.1016/j.fct.2013.11.015. Epub 2013 Nov 22.
8
Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease the Sirt1/AMPK and NF-κB signaling pathways.丙烯基异硫氰酸酯通过 Sirt1/AMPK 和 NF-κB 信号通路改善非酒精性脂肪性肝病中的脂质积累和炎症。
World J Gastroenterol. 2019 Sep 14;25(34):5120-5133. doi: 10.3748/wjg.v25.i34.5120.
9
Curcumin regulates endogenous and exogenous metabolism via Nrf2-FXR-LXR pathway in NAFLD mice.姜黄素通过 Nrf2-FXR-LXR 通路调节非酒精性脂肪性肝病小鼠的内源性和外源性代谢。
Biomed Pharmacother. 2018 Sep;105:274-281. doi: 10.1016/j.biopha.2018.05.135. Epub 2018 May 31.
10
Yangonin protects against non-alcoholic fatty liver disease through farnesoid X receptor.杨芽素通过法尼醇 X 受体保护非酒精性脂肪性肝病。
Phytomedicine. 2019 Feb;53:134-142. doi: 10.1016/j.phymed.2018.09.006. Epub 2018 Sep 5.

引用本文的文献

1
Exploring the interplay between metabolic dysfunction-associated fatty liver disease and gut dysbiosis: Pathophysiology, clinical implications, and emerging therapies.探索代谢功能障碍相关脂肪性肝病与肠道菌群失调之间的相互作用:病理生理学、临床意义及新兴疗法。
World J Hepatol. 2025 Aug 27;17(8):108730. doi: 10.4254/wjh.v17.i8.108730.
2
Exploring hepatic stellate cell-driven fibrosis: therapeutic advances and future perspectives.探索肝星状细胞驱动的纤维化:治疗进展与未来展望
ADMET DMPK. 2025 Aug 4;13(4):2874. doi: 10.5599/admet.2874. eCollection 2025.
3
Unlocking therapeutic potential: exploring cross-talk among emerging nuclear receptors to combat metabolic dysfunction in steatotic liver disease.
释放治疗潜力:探索新兴核受体之间的相互作用以对抗脂肪性肝病中的代谢功能障碍。
NPJ Metab Health Dis. 2024 Jul 3;2(1):13. doi: 10.1038/s44324-024-00013-6.
4
Unlocking the gut-liver axis: microbial contributions to the pathogenesis of metabolic-associated fatty liver disease.揭示肠-肝轴:微生物在代谢相关脂肪性肝病发病机制中的作用
Front Microbiol. 2025 Apr 25;16:1577724. doi: 10.3389/fmicb.2025.1577724. eCollection 2025.
5
The Active Components of Traditional Chinese Medicines Regulate the Multi-Target Signaling Pathways of Metabolic Dysfunction-Associated Fatty Liver Disease.中药活性成分调控代谢功能障碍相关脂肪性肝病的多靶点信号通路
Drug Des Devel Ther. 2025 Apr 9;19:2693-2715. doi: 10.2147/DDDT.S514498. eCollection 2025.
6
Targeting AMPK related signaling pathways: A feasible approach for natural herbal medicines to intervene non-alcoholic fatty liver disease.靶向AMPK相关信号通路:天然草药干预非酒精性脂肪性肝病的可行方法。
J Pharm Anal. 2025 Jan;15(1):101052. doi: 10.1016/j.jpha.2024.101052. Epub 2024 Aug 5.
7
Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.双重麻烦:微生物群失调和线粒体功能障碍如何引发非酒精性脂肪性肝病和非酒精性脂肪性肝炎。
Biomedicines. 2024 Feb 29;12(3):550. doi: 10.3390/biomedicines12030550.
8
Fecal microbiota transplantation for treatment of non-alcoholic fatty liver disease: Mechanism, clinical evidence, and prospect.粪便微生物群移植治疗非酒精性脂肪性肝病:机制、临床证据与展望。
World J Gastroenterol. 2024 Feb 28;30(8):833-842. doi: 10.3748/wjg.v30.i8.833.
9
Combination of Formononetin and Sulforaphane Natural Drug Repress the Proliferation of Cervical Cancer Cells via Impeding PI3K/AKT/mTOR Pathway.芒柄花素与萝卜硫素联合天然药物通过阻断PI3K/AKT/mTOR信号通路抑制宫颈癌细胞增殖。
Appl Biochem Biotechnol. 2024 Oct;196(10):6726-6744. doi: 10.1007/s12010-024-04873-y. Epub 2024 Feb 24.
10
Angelica dahurica extract and its effective component bergapten alleviated hepatic fibrosis by activating FXR signaling pathway.白芷提取物及其有效成分佛手柑内酯通过激活 FXR 信号通路缓解肝纤维化。
J Nat Med. 2024 Mar;78(2):427-438. doi: 10.1007/s11418-024-01780-8. Epub 2024 Feb 9.